Obstructive sleep apnea and heart disease: the biomarkers point of view

Frontiers in Bioscience - Scholar

Volumn 5 S, Issue 2, 2013, Pages 588-599

  Vitulano, Nicola ^a   Di Marco Berardino, Alessandro ^a   Re, Antonina ^a   Riccioni, Graziano ^b   Perna, Francesco ^a   Mormile, Flaminio ^a   Valente, Salvatore ^a   Bellocci, Fulvio ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b SAN CAMILLO DE LELLIS HOSPITAL   (Italy)

Author keywords

Biomarkers; Cardiovascular disease; Cytokines; Inflammation; Obstructive sleep apnea; Review

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; ANTIHYPERTENSIVE AGENT; BIOLOGICAL MARKER; C REACTIVE PROTEIN; CREATINE KINASE; CYSTEINE; GRANULOCYTE CHEMOTACTIC PROTEIN 2; HOMOCYSTEINE; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; REACTIVE OXYGEN METABOLITE; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

ALCOHOL CONSUMPTION; ANTIHYPERTENSIVE THERAPY; ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART DISEASE; HEART FAILURE; HEART VENTRICLE BIGEMINY; HEART VENTRICLE TACHYCARDIA; HUMAN; HYPERTENSION; INCIDENCE; INFLAMMATION; OBESITY; OXIDATIVE STRESS; OXYGEN DESATURATION; OXYGEN SATURATION; POLYSOMNOGRAPHY; POSITIVE END EXPIRATORY PRESSURE; REVIEW; SLEEP DISORDERED BREATHING; SMOKING; CARDIOVASCULAR DISEASE; METABOLISM; PATHOLOGY; PREVALENCE; RISK FACTOR;

BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; CONTINUOUS POSITIVE AIRWAY PRESSURE; HUMANS; PREVALENCE; RISK FACTORS; SLEEP APNEA, OBSTRUCTIVE;

EID: 84883720982     PISSN: 19450516     EISSN: 19450524     Source Type: Journal    
DOI: 10.2741/s392     Document Type: Review

References (133)

1. M T Naughton, G Lorenzi-Filho: Sleep in heart failure. Progress in Cardiovascular Disease 51, 339-49 (2009)
2. J Kim, K In, J Kim, S You, K Kong, J Shim, S Lee, J Lee, S Lee, C Park, C Shin: Prevalence of sleep-disordered breathing in middle-aged Korean men and women. Am J Respir Crit Care Med 170, 1108-1113. (2004)
3. Y Nakayama-Ashida, M Takegami, K. Chin, K. Sumi, T. Nakamura, K. Takahashi, T.Wakamura, S. Horita, Y. Oka, I. Minami, S. Fukuhara, H. Kadotani: Sleep-disorder breathing in the usual lifestyle setting as detected with home monitoring in a population of working men in Japan. Sleep; 31: 419-425.( 2008)
4. E O Bixler, A N Vgontzas, H M Lin, T Ten Have, J Rein, A Vela-Bueno, A Kales: Prevalence of sleepdisordered breathing in women: effects of gender. American J Respir Criti Care Med 157, 144-148 (2001)
5. W T McNicholas, M R Bonsignore Clinical presentations of OSA in adults. In: European Respiratory monograph. Sleep apnoea. Chapter 6 Clinical presentations of OSA in adults. Eds: P Powell, F Marks, C Pumphrey, European Respiratory Society 442 Glossop Road, Sheffield S10 2 PX, UK (2010) ISBN: 978-1-84984-007-1
6. J Herscovitch, R Broughton: Sensitivity of the Stanford Sleepiness Scale to the effects of cumulative partial sleep deprivation and recovery oversleeping. Sleep 4, 83-91 (1981)
7. M.W. Johns: A new method for measuring daytime sleepiness: The Epwoth Sleepiness Scale. Sleep 14, 540-545 (1991)
8. M R Littner, C Kushida, M Wise, D G Davila, T Morgenthaler, T Lee-Chiong, M Hirshkowitz, L L Daniel, D Bailey, R B Berry, S Kapen, M Kramer: Standards of Practice Committee of the American Academy of Sleep Medicine: Practice parameters for clinical use of the multiple sleep latency test and the maintenace of wakefullness test. Sleep 28, 113-121 (2005)
9. C Janson, T Gislason, W De Backer, P Plaschke, E Björnsson, J Hetta, H Kristbjarnason, P Vermeire, G Boman: Daytime sleepiness, snoring and gastrooesophageal reflux among young adults in three European country. J Intern Med, 277-285 (1995)
10. E Lindberg, A Taube, C Janson, T Gislason, K Svärdsudd, G Boman: A 10-year follow-up of snoring in men. Chest 114, 1048-1055 (1998)
11. T Young, P E Peppard, D J Gottlieb: Epidemiology of obstructive sleep apnea: a population health perspective. Am J Respir Critic Care Med 165, 1217-1239 (2002)
12. L J Epstein, D Kristo, P J Jr Strollo, N Friedman, A Malhotra, S P Patil, K Ramar, R Rogers, R J Schwab, E M Weaver, M D Weinstein; Adult Obstructive Sleep Apnea Task Force of the American Academy of Sleep Medicine: Clinical guidelines for the evaluation, management and long-term care pf obstructive sleep apnea in adults. J Clin Sleep Med 5, 263-276 (2009)
13. S P Patil, H Schneider, A R Schwartz, P L Smith: Adult obstructive sleep apnea: pathophysiology and diagnosis. Chest; 132: 325-337 (2007)
14. M H Sanders, J M Montserrat, R Farrè, R J Givelber. Positive pressure therapy: a perspective on evidence-based outcomes and methods of application. Proc An Thor Soc 5, 161-172 (2008)
15. T E Weaver, G Maislin, D F Dinges, T Bloxham, C F George, H Greenberg, G Kader, M Mahowald, J Younger, A I Pack . Relatioship between hours of CPAP use and achieving normal levels of sleepiness and daily funtioning. Sleep; 30: 711-719. (2007)
16. P Haentjens, A Van Meerhaeghe, A Moscariello, S De Weerdt, K Poppe, A Dupont, B Velkeniers: The impact of continous positive air way pressure on blood pressure in patients with obstructive sleep apnea syndrome: evidence from a meta-analysis of placebo controller randomized trials. Arch Intern Med 167, 757-764. (2007)
17. J M Marin, S J Carrizo, E Vicente, G Agusti: Longterm cardiovascular outcomes in men with obstructive sleep apnea-hypopnea with or without treatment with continous positive air way pressure: an observational study. Lancet 365: 1046-1053 (2005)
18. K Johansson, M Neovius, Y T Lagerros, R Harlid, S Rössner, F Granath, E. Hemmingsson: Effect of a very low Energy diet on moderate and severe obstructive sleep apnoea in obese men: a randomised controlloed trial. BMJ 3, 339:b4609 (2009)
19. H P Tuomilehto, J M Seppä, M M Partinen, M Peltonen, H Gylling, J O Tuomilehto, E J Vanninen, J Kokkarinen, J K Sahlman, T Martikainen, E J Soini, J Randell, H Tukiainen, M Uusitupa: Kuopio Sleep Apnea Group: Lifestyle intervention with weight reduction: firsline treatment in mild obstructive sleep apnea. Am J Respir Critic Care Med 179, 320-327 (2009)
20. M Koskenvuo, J Kaprio, M Partinen, H Langinvainio, S Sarna, K Heikkila: Snoring as a risk factor for hypertension and angina pectoris. Lancet 1, 893-6 (1985)
21. F J Nieto, T B Young, B K Lind, E Shahar, J M Samet, S Redline, R B D'Agostino, A B Newman, M D Lebowitz, T G Pickering: Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study. Sleep Heart Health Study. JAMA 283 (14), 1829-36 (2000)
22. K M Hl, T B Young, T Bidwell, M Palta, J B Skatrud, J Dempsey: Sleep apnea and hypertension. A populationbased study. Ann Intern Med 120(5), 382-8 (1994)
23. P E Peppard, T Young, M Palta, J Skatrud: Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med 342, 1378-84 (2000)
24. D S Silverberg, A Oksenberg, A Iaina: Sleep-related breathing disorders as a major cause of essential hypertension: fact or fiction? Curr Opin Nephrol Hypertens, 7, 353-357 (1998)
25. E C Fletcher, R D DeBehnke, M S Lovoi, A B Gorin: Undiagnosed sleep apnea in patients with essential hypertension. Ann Intern Med 103, 190-195 (1985)
26. A Kales, E O Bixler, R J Cadieux, D W Schneck, L C Shaw 3rd, T W Locke, A Vela-Bueno, C R Soldatos: Sleep apnoea in a hypertensive population. Lancet 2, 1005-1008 (1984)
27. P Lavie, R. Ben-Yosef, A.E. Rubin: Prevalence of sleep apnea syndrome among patients with essential hypertension. Am Heart J, 108, pp. 373-376. (1984)
28. S. Vardan, M H Dunsky, N E Hill, S Mookherjee, H Smulyan, R A Warner: Systemic systolic hypertension in the elderly: correlation of hemodynamics, plasma volume, renin, aldosterone, urinary metanephrines and response to thiazide therapy. Am J Cardiol, 58, 1030-1034 (1986)
29. A J Williams, D Houston, S Finberg, C Lam, J L Kinne, S Santiag: Sleep apnea syndrome and essential hypertension. Am J Cardiol, 55, 1019-1022 (1985)
30. D C Haas, G L Foster, F J Nieto, S Redline, H E Resnick, J A Robbins, T Young, T G Pickering: Agedependent associations between sleep-disordered breathing and hypertension: importance of discriminating between systolic/diastolic hypertension and isolated systolic hypertension in the Sleep Heart Health Study. Circulation 111, 614-621 (2005)
31. A G Logan, S M Perlikowski, A Mente, A Tisler, R Tkacova, M Niroumand, R S Leung, T D Bradley: High prevalence of unrecognized sleep apnoea in drugresistant hypertension. J Hypertens, 19, 2271-2277 (2001)
32. National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee, A V Chobanian, G L Bakris, H R Black, W C Cushman, L A Green, J L Izzo, D W Jones, B J Materson, S Oparil, J T Wright, E J Roccella: The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 report. JAMA 289, 2560-2572 (2003)
33. J T Carlson, J Hedner, M Elam, H Ejnell, J Sellgren, B G Wallin: Augmented resting sympathetic activity in awake patients with obstructive sleep apnea. Chest 103, 1763-1768 (1993)
34. Y Peker, H Kraiczi, J Hedner, S Löth, A Johansson, M Bende: An independent association between obstructive sleep apnoea and coronary artery disease. Eur Respir J 14, 179-184 (1999)
35. E Shahar, C W Whitney, S Redline, E T Lee, A B Newman, N F Javier, G T O'Connor, L L Boland, J E Schwartz, J M Samet: Sleep-disordered breathing and cardiovascular disease: cross-sectional results of the Sleep Heart Health Study. Am J Respir Crit Care Med 163, 19-25 (2001).
36. P C Waller, R S Bhopal: Is snoring a cause of vascular disease? An epidemiological review. Lancet 1, 143-146 (1989)
37. Y Peker, J Hedner, H Kraiczi, S Loth: Respiratory disturbance index: an independent predictor of mortality in coronary artery disease. Am J Respir Crit Care Med 162, 81-86 (2000)
38. D Sorajja, A S Gami, V K Somers, T R Behrenbeck, A Garcia-Touchard, F Lopez-Jimenez: Independent association between obstructive sleep apnea and subclinical coronary artery disease. Chest 133, 927-933 (2008)
39. P Hanly, Z Sasson, N Zuberi, K Lunn: ST-segment depression during sleep in obstructive sleep apnea. Am J Cardiol 71, 1341-1345 (1993)
40. A S Gami, A Svatikova, R Wolk, E J Olson, C J Duenwald, A S Jaffe, V K Somers: Cardiac troponin T in obstructive sleep apnea. Chest 125, 2097-2100 (2004)
41. T Mooe, K A Franklin, K Holmström, T Rabben, U Wiklund: Sleep-disordered breathing and coronary artery disease: long-term prognosis. Am J Respir Crit Care Med 164, 1910-1913 (2001)
42. C Guilleminault, S J Connolly, R A Winkle: Cardiac arrhythmia and conduction disturbances during sleep in 400 patients with sleep apnea syndrome. Am J Cardiol 52, 490-494 (1983)
43. V Hoffstein, S Mateika. Cardiac arrhythmias, snoring, and sleep apnea. Chest 106, 466-471 (1994)
44. R Mehra, E J Benjamin, E Shahar, D J Gottlieb, R Nawabit, H L Kirchner, J Sahadevan, S Redline: Association of nocturnal arrhythmias with sleepdisordered breathing: The Sleep Heart Health Study. Am J Respir Crit Care Med 173, 910-916 (2006)
45. S Javaheri, T J Parker, J D Liming, W S Corbett, H Nishiyama, L Wexler, G A Roselle: Sleep apnea in 81 ambulatory male patients with stable heart failure: Types and their prevalences, consequences, and presentations. Circulation 97, 2154-9 (1998)
46. J Harbison, P O'Reilly, W T McNicholas: Cardiac rhythm disturbances in the obstructive sleep apnea syndrome: effects of nasal continuous positive airway pressure therapy. Chest 118, 591-595 (2000)
47. J W Jr Shepard, M W Garrison, D A Grither, G F Dolan: Relationship of ventricular ectopy to oxyhemoglobin desaturation in patients with obstructive sleep apnea. Chest 88, 335-340 (1985)
48. C M Ryan, S Juvet, R Leung, T D Bradley: Timing of nocturnal ventricular ectopy in heart failure patients with sleep apnea. Chest 133, 934-940 (2008)
49. S Javaheri: Effects of continuous positive airway pressure on sleep apnea and ventricular irritability in patients with heart failure. Circulation 101, 392-7 (2000)
50. N Vitulano, G Giubilato, P Santangeli, C Ierardi, M Pieroni, F Bellocci, F Crea: Continuous positive airway pressure treatment in addition to optimal medical therapy for ventricular ectopy in a patient with heart failure and sleep-related breathing disorder. J Cardiovasc Med (Hagerstown) 7, (2009)
51. A S Gami, D O Hodge, R M Herges, E J Olson, J Nykodym, T Kara, V K Somers: Obstructive sleep apnea, obesity, and the risk of incident atrial fibrillation. J Am Coll Cardiol 49, 565-571 (2007)
52. U Koehler, E Fus, W Grimm, W Pankow, H Schafer, A Stammnitz, J H Peter: Heart block in patients with obstructive sleep apnoea: pathogenetic factors and effects of treatment. Eur Respir J 11, 434-439 (1998)
53. C Zwillich, T Devlin, D White, N Douglas, J Weil, R Martin: Bradycardia during sleep apnea. Characteristics and mechanism. J Clin Invest 69, 1286-1292 (1982)
54. H Becker, U Brandenburg, J H Peter, P Von Wichert: Reversal of sinus arrest and atrioventricular conduction block in patients with sleep apnea during nasal continuous positive airway pressure. Am J Respir Crit Care Med 151, 215-218 (1995)
55. W Grimm, J Hoffmann, V Menz, U Kohler, J Heitmann, J H Peter, B Maisch: Electrophysiologic evaluation of sinus node function and atrioventricular conduction in patients with prolonged ventricular asystole during obstructive sleep apnea. Am J Cardiol 77, 1310-1314 (1996)
56. N Vitulano, F Bellocci: Sleep-related breathing disorder and bradyarrhythmias, why to use continuous positive airway pressure (CPAP) treatment: a case report. Clin Ter 162 (4), 357-9 (2011)
57. D Yumino, H Wang, J S Floras, G E Newton, S Mak, P Ruttanaumpawan, J D Parker, T D Bradley. Prevalence and physiological predictors of sleep apnea in patients with heart failure and systolic dysfunction. J Card Fail 15(4), 279-85 (2009)
58. K Ferrier, A Campbell, B Yee, M Richards, T O'Meeghan, M Weatherall, A Neill: Sleep-disordered breathing occurs frequently in stable outpatients with congestive heart failure. Chest 128(4), 2116-22 (2005)
59. A Vazir, P C Hastings, M Dayer, H F McIntyre, M Y Henein, P A Poole-Wilson, M R Cowie, M J Morrell, A K Simonds: A high prevalence of sleep disordered breathing in men with mild symptomatic chronic heart failure due to left ventricular systolic dysfunction. Eur J Heart Fail 9 (3), 243-50 (2007)
60. J Chan, J Sanderson, W Chan, C Lai, D Choy, A Ho, R Leung: Prevalence of sleep-disordered breathing in diastolic heart failure. Chest 111 (6), 1488-93 (1997)
61. Javaheri S: Sleep disorders in systolic heart failure: a prospective study of 100 male patients. The final report. Int J Cardiol 106(1), 21-28 (2006)
62. H Wang, J D Parker, G E Newton, J S Floras, S Mak, K L Chiu, P Ruttanaumpawan, G Tomlinson, T D Bradley: Influence of obstructive sleep apnea on mortality in patients with heart failure. J Am Coll Cardiol 49, 1625-31 (2007)
63. D D Sin, F Fitzgerald, J D Parker, G Newton, J S Floras, T D Bradley: Risk factors for central and obstructive sleep apnea in 450 men and women with congestive heart failure. Am J Respir Crit Care Med 160, 1101-1106 (1999)
64. O Oldenburg, B Lamp, L Faber, H Teschler, D Horstkotte, V Töpfer: Sleep-disordered breathing in patients with symptomatic heart failure: a contemporary study of prevalence in and characteristics of 700 patients. Eur J Heart Failure 9, 251-7 (2007)
65. L Patrick, R Tamisier, C Arnaud, D Monneret, J P Baguet, F Stanke-Labesque, M Dematteis, D Godin-Ribuot, C Ribuot, J L Pepin: Sleep Deprivation, Sleep Apnea And Cardiovascular Diseases. Front Biosc E4 1, 2007-2021 (2012)
66. L Lavie: Obstructive sleep apnoea syndrome-an oxidative stress disorder. Sleep Med Rev 7 (1), 35-51 (2003)
67. C Ryan, C T Taylor, W T McNicholas: Systemic inflammation: a key factor in the pathogenesis of cardiovascular complications in obstructive sleep apnea syndrome? Thorax 64, 631-636 (2009)
68. L Dyugovskaya, P Lavie, M Hirsh, L Lavie: Activated CD8+ T-lymphocytes in obstructive sleep apnoea. Eur Respir J 25, 820-828 (2005)
69. L Dyugovskaya, P Lavie, L Lavie: Increased adhesion molecules expression and production of reactive oxygen species in leukocytes of sleep apnea patients. Am J Respir Crit Care Med 165, 934-939 (2002)
70. L Dyugovskaya, P Lavie, L Lavie: Phenotypic and functional characterization of blood gammadelta T cells in sleep apnea. Am J Respir Crit Care Med 168, 242-249 (2003)
71. L Dyugovskaya, P Lavi, L Lavie: Lymphocyte activation as a possible measure of atherosclerotic risk in patients with sleep apnea. Ann N Y Accad Sci 1051, 340-350 (2005)
72. C T Taylor: Interdependent roles for hypoxia inducible factor and nuclear factor-kappaB in hypoxic inflammation. J Physiol 586, 4055-4059. (2008)
73. S Ryan, W T McNicholas, C T Taylor: A critical role for p38 map kinase in NF-kappaB signaling during intermittent hypoxia/reoxygenation. Biochem Biophys Res Commun 355, 728-733 (2007)
74. S Ryan, C T Taylor, W T McNicholas: Predictors of elevated nuclear factorkappaB-dependent genes in obstructive sleep apnea syndrome. Am J Respir Crit Care Med 174, 824-830 (2006)
75. L Lavie: Oxidative inflammation and endothrlial dysfunction in obstructive sleep apnea. Front Biosc E4, 1391-1403 (2012)
76. M Hayakaw, H Miyashita, I Sakamoto, M Kitagawa, H Tanaka, H Yasuda, M Karin, K Kikugawa: Evidence that reactive oxygen species do not mediate NF-kappaB activation. EMBO J 22, 3356-3366 (2003)
77. C Gabay, I Kushner: Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 340 (6), 448-454 (1999)
78. E T H Yeh, J T Willerson: Coming of age of C-reactive protein. Using inflammation markers in cardiology. Circulation 107: 370 (2003)
79. R Ross: Atherosclerosis-an inflammatory disease. N Engl J Med 340: 115-126 (1999)
80. G Liuzzo, L M Biasucci, J R Gallimore, R L Grilli, A G Rebuzzi, M B Pepys, A Maseri: Prognostic value of C Reactive Protein and Serum Amyloid A Protein in severe unstable angina. N Engl J Med 331, 417-424 (1994)
81. W Koenig: Predicting risk and treatment benefit in atherosclerosis: The role of C-reactive protein. Intern J Cardiol 98: 199-206 (2005)
82. V Pasceri, J T Willerson, E T H Yeh: Direct proinflammatory effect of c-reactive protein on human endothelial cells. Circulation 102, 2165-2168 (2000)
83. J T Willerson, P M Ridker: Inflammation as a vascular risk factor. Circulation 109 (21) supplement II, II-2-II-10 (2004)
84. H K Meier-Ewert, P M Ridker, N Rifai, M M Regan, N J Price, D F Dinges, J M Mullington: Effect of sleep loss on C-reactive protein, an inflammatory marker of cardiovascular risk. J Am Coll Cardiol 43, 678-683 (2004)
85. A N Vgontzas, D A Papanicolaou, E O Bixler, A Kales, K Tyson, G P Chrousos: Elevation of plasma cytokines in disorders of excessive daytime sleepiness: role of sleep disturbance and obesity. J Clin Endocrinol Metab 82, 1313-1316 (1997)
86. A S Shamsuzzaman, M Winnicki, P Lanfranchi, R Wolk, T Kara, V Accurso, V K Somers: Elevated Creactive protein in patients with obstructive sleep apnea. Circulation 105, 2462-2464 (2002)
87. E K Larkin, C L Rosen, H L Kirchner, A Storfer-Isser, J L Emancipator, N L Johnson, A M Zambito, R P Tracy, N S Jenny, S Redline: Variation of C-reactive protein levels in adolescents: association with sleepdisordered breathing and sleep duration. Circulation 111, 1978-1984 (2005)
88. N M Punjabi, B A Beamer: C-reactive protein is associated with sleep disordered breathing independent of adiposity. Sleep 30, 29-34 (2007)
89. T Yokoe, K Minoguchi, H Matsuo, N Oda, H. Minoguchi, G Yoshino, T Hirano, M Adachi: Elevated levels of C-reactive protein and interleukin-6 in patients with obstructive sleep apnea syndrome are decreased by nasal continuous positive airway pressure. Circulation 107, 112934 (2003)
90. O K Basoglu, F Sarac, S Sarac, H Uluer, Y Candeger: Metabolic syndrome, insulin resistance, fibrinogen, homocysteine, leptin, and C-reactive protein in obese patients with obstructive sleep apnea syndrome. Ann Thorac Med 6 (3), 120-125 (2011)
91. D Gozal, L Kheirandish-Gozal, R Bhattacharjee, J Kim: C-reactive protein and obstructive sleep apnea syndrome in children. Front Biosc E4, 2410-2422 (2012)
92. J A de Lemos, D K McGuire, M H Drazner: B-type natriuretic peptide in cardiovascular disease. Lancet 362 (9380), 316-322 (2003)
93. T J Wang, M G Larson, D Levy, E J Benjamin, E P Leip, T Omland, P A Wolf, R S Vasan: Plasma natriuretic peptide levels and the risk of cardiovascular events and death. N Engl J Med 350 (7), 655-63 (2004)
94. R Witthaut: Science review: natriuretic peptides in critical illness. Crit Care 8 (5), 342-349 (2004)
95. A M Richards, M G Nicholls, E A Espiner, J G Lainchbury, R W Troughton, J Elliott, C Frampton, J Turner, I G Crozier, T G Yandle: B-type natriuretic peptides and ejection fraction for prognosis after myocardial infarction. Circulation 107(22), 2786-2792 (2003)
96. H Kita, M Ohi, K Chin, T Noguchi, N Otsuka, T Tsuboi, H Itoh, K Nakao, K Kuno: The nocturnal secretion of cardiac natriuretic peptides during obstructive sleep apnoea and its response to therapy with nasal continuous positive airway pressure. J Sleep Res 7 (3), 199-207 (1998)
97. R H Hübner, N E El Mokhtari, S Freitag, T Rausche, R Göder, A Tiroke, M Lins, R Simon, B Bewig: NT-proBNP is not elevated in patients with obstructive sleep apnoea. Respir Med 102(1), 134-142 (2008)
98. J D Finkelstei, J J Martin. Homocysteine: Int J Biochem Cell Biol 32 (4), 385-389 (2000)
99. I M Graham, L E Daly, H M Refsum, K Robinson, L E Brattström, P M Ueland, R J Palma-Reis, G H Boers, R G Sheahan, B Israelsson, C S Uiterwaal, R Meleady, D McMaster, P Verhoef, J Witteman, P Rubba, H Bellet, J C Wautrecht, H W de Valk, A C Sales Luis, F M Parrot-Rouland, K S Tan, I Higgins, D Garcon, G Andria: Plasma Homocysteine as a risk factor for vascular disease. The European Cocerted Action project. JAMA 277, 1775-1781 (1997)
100. J S Stamler, J A Osborne, O Jaraki, L E Rabbani, M Mullins, D Singel, J Loscalzo. Adverse vascular effects of Homocysteine are modulated by endothelium-derived relaxing factor and related oxides of nitrogen. J Clin Invest 91, 308-318 (1993)
101. Y Ozkan, H Firat, B Simsek, M Torun, S Yardim-Akaydin: Circulating nitric oxide (NO), asymmetric dimethylarginine (ADMA), homocysteine, and oxidative status in obstructive sleep apnea-hypopnea syndrome (OSAHS). Sleep Brea 12, 149-154 (2008)
102. L Wang, J Li, Y Xie, X G Zhang: Association between serum homocysteine and oxidative stress in elderly patints with obstructive sleep apnea/hyponea syndrome. Bioc Envir Sci 23, 42-47 (2010)
103. L Lavie, A Perelman, P Lavie: Plasma homocysteine levels in obstructive sleep apnea, association with cardiovascular morbidity. Chest 120, 900-908 (2001)
104. O Kokturk, T U Ciftci, E Mollarecep, B Ciftci: Serum homocysteine levels and cardiovascular morbidity in obstructive sleep apnea syndrome. Resp Med 100, 536-541 (2006)
105. M Can, S A?kg?, G Mungan, T Bayraktaroglu, E Koçak, B Güven, S Demirtas: Serum cardiovascular risk factors in obstructive sleep apnea. Chest 129, 233-237 (2006)
106. N Sariman, E Levent, F B Aksungar, A C Soylu, O Bektas: Homocysteine levels and echocardiographic findings in obstructive sleep apnea syndrome. Resp 79, 38-45 (2010)
107. M Chen, B Wu, X Ye, Z Zhou, X Yue, Q Wang, W Wang, Y Jiang, X Lian, Z Chen, G Xu, X Liu: Association between plasma hocysteine levels and obstructive sleep apnoea in patints with ischaemic stroke. J Clin Neur 18, 1454-1457 (2011)
108. M Kumor, P Bielicki, T Przybylowski, R Rubinsztajn, J Zielinski, Ryszarda C: Three-month continous positive airway pressure (CPAP) treatment decreases total and LDLcholesterol levels but does not affect serum homocysteine and leptin levels in patients with obstructive sleep apnoea syndrome (OSAS) without co-existent ischaemic heart disease (IHD). Pneum Alerg Pol 79 (3), 173-183 (2011)
109. A Svatikova, R Wolk, M J Magera, A S Shamsuzzaman, B G Phillips, V K Somers: Plasma homocysteine in obstructive sleep apnoea. Eur Heart J 25, 1325-1329 (2004)
110. Y Ozkan, E Ozkan, B Simsek: Plasma total homocysteine and cysteine levels as cardiovascular risk factors in coronary heart disease. Int J Cardiol 82 (3), 269-277 (2002)
111. F Cintra, S Tufik, V D'Almeida, B F Calegare, A de Paola, W Oliveira, C Rizzi, S Roizenblatt, D Poyares: Cysteine: a pontential biomarker for obstructive sleep apnea. Chest 139 (2), 246-252 (2011)
112. M Cesari, B W Penninx, A B Newman, S B Kritchevsky, B J Nicklas, K Sutton-Tyrrell, S M Rubin, J Ding, E M Simonsick, T B Harris, M Pahor: Inflammatory markers and onset of cardiovascular events results from the Health ABC study. Circulation 108, 2317 (2003)
113. S Ryan, C T Taylor, W T McNicholas: Selective activation of inflammatory pathways by intermittent hypoxia in obstructive sleep apnea syndrome. Circulation 112, 2660-2667 (2005)
114. J Huang, N Liao, Q P Huang, Z F Xie: Association between tumoe necrosis factor-alpha-308G/A polymorphism and obstructive sleep apnea: a meta-analysis. Genet Tst Mol Biomark 11, (2011)
115. M A Arias, F García-Río, A Alonso-Fernández, A Hernanz, R, V Martínez-, S Bartolomé, L Rodríguez-Padial: CPAP decreases plasma levels of soluble tumor necrosis factor-alpha receptor 1 in obstructive sleep apnoea. Eur Resp J 32 (4), 1009-1015 (2008
116. F. Sarac, K Basoglu, C Gunduz, H Bayrak, C Biray Avci, F Akcicek: Association of osteopontin and tumor necrosis factor-alpha levels with insuline resistance in pbese patients with obstructive sleep apnea syndrome. J Endocrinol Invest 34 (7), 528-533 (2011)
117. A N Vgontzas, E Zoumakis, H M Lin, E O Bixler, G Trakada, G P Chrousos. Marked decrease in sleepiness in patints with sleep apnea by etanercept, a tumor necrosis factor alpha antagonist: J Clin Endocrinol Metab 89 (9), 4409-4413 (2004)
118. T U Ciftci, O Kokturk, N Bukan, A Bilgihan. The relationship between serum cytokine levels with obesity and obstructive sleep apnea syndrome: Cytokine 28, 87-91 (2004)
119. R Mehra, A Storfer-Isser, H L Kirchner, N Johnson, N Jenny, R P Tracy, S Redline: Soluble interleukin 6 receptor: a novel marker of moderate to severe sleeprelated breathing disorder. Arch Intern Med 166, 1725-1731 (2006)
120. Aukrust P, Yndestad A, Smith C, Ueland T, Gullestad L, Damas J K: Chemokines in cardiovascular risk prediction. Thromb Haemost 97(5), 748-54 (2007). 121. R E Gerszten, E A Garcia-Zepeda, Y C Lim, M Yoshida, H A Ding, M A Gimbrone Jr, A D Luster, F W Luscinskas, A Rosenzweig: MPC-1 and IL-8 trigger firm adhesion of monocytes to vascular endothelium under flow condition. Nature 398, 718-723 (1999)
121. E Ohga, T Tomita, H Wada, H Yamamoto, T Nagase, Y Ouchi: Effects of obstructive sleep apnea on circulating ICAM-1, IL-8 and MCP-1. J Appl Physiol 94, 179-184 (2003)
122. M A Alzoghaibi, A S Bahammam: Lipid peroxides, superoxide dismutase and circulating IL-8 and GCP-2 in patients with severe obstructive sleep apnea: apilot study. Sleep Breath 9, 119-126 (2005)
123. S J Hwang, C M Ballantyne, A R Sharrett, L C Smith, C E Davis, A M Gotto Jr, E Boerwinkle: Circulating adhesion molecules VCAM-1, ICAM-1 and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: The atherosclerosis risk in communities (ARIC) study. Circulation 96, 4219-25 (1997)
124. M Haim, D Tanne, V Boyko, T Reshef, U Goldbourt, J Leor, Y A. Mekori, S Behar: Soluble intercellular adhesion molecule-1 and long-term risk of acute coronary events in patients with chronic coronary heart disease. Data from the Bezafibrate infarction prevention (BIP) study. J Am Coll Cardiol 39, 1133-1138 (2002)
125. E Ohga, T Nagase, T Tomita, S Teramoto, T Matsuse, H Katayama, Y Ouchi: Increased levels of circulating ICAM-1, VCAM-1 and L-selectin in obstructive apnea syndrome. J Appl Physiol 87, 10-14 (1999)
126. A A El-Solh, M J Mador, P Sikka, R S Dhillon, D Amsterdam, B J Grant: Adhesion molecole in patients with coronary artery disease and moderate-to.severe obstructive sleep apnea. Chest 121, 1541-1547 (2002)
127. K Chin, T Nakamura, K Shimizu, M Mishima, T Nakamura, M Miyasaka, M Ohi: Effects of nasal continous positive airway pressure on soluble cell adhesion molecules in patients with obstructive sleep apnea. Am J Med 109, 562-567 (2000)
128. A Ursavas, M Karadag, E Rodoplu, A Yilmaztepe, H B Oral, R O Gözü: Circulating ICAM-1 and VCAM-1 levels in patients with obstructive sleep apnea syndrome. Resp 74 (5), 525-32 (2007)
129. C Zamarrón-Sanz, J Ricoy-Galbaldon, F Gude-Sampedro, A Riveiro-Riveiro: Plasma levels of vascular endothelial markers in obstructive sleep apnea. Arch Med Resp 37 (4), 552-5 (2006)
130. R von Känel, J E Dimsdale: Hemostatic alterations in patients with obstructive sleep apnea and the implication for cardiovascular disease. Chest 124, 1956-1967 (2003)
131. P Steiropoulos, N Papanas, E Nena, M Antoniadou, E Serasli, S Papoti, O Hatzizisi, G Kyriazis, A Tzouvelekis, E Maltezos, V Tsara, D Bouros: Inflammatory markers in middle-aged obese subjects: does obstructive sleep apnea syndrome play a role? Med Inflam ID 675320, 6 pp (2010)
132. S Lentini, R Manka, S Scholtyssek, B Stoffel-Wagner, B Lüderitz, S Tasci: Creatinine phosphokinase elevation in obstructive sleep apnea syndrome: an unknown association? Chest 129, 88-94 (2006)
133. J Kim, R Bhattacharjee, L Kheirandish-Gozal, K Spruyt, D Gozal: Circulating microparticles in children with sleep disordered breathing. Chest 140 (2), 408-417 (2011)